To ascertain whether the upregulation of TRIB3 induced by sorafenib contributes to therapeutic resistance, we established sorafenib therapeutic strategy in mice bearing orthotropic Hepa1‐6 cell‐derived hepatoma or hydrodynamic force‐induced spontaneous hepatoma. The gene discussed is TRIB3; the disease is hepatocellular carcinoma.